Overview
Yara Khalil-Abou practices in Beirut, Lebanon. Ms. Khalil-Abou is rated as an Experienced expert by MediFind in the treatment of Apolipoprotein C2 Deficiency. Her top areas of expertise are Familial Hypercholesterolemia, Hypolipoproteinemia, Homozygous Familial Hypercholesterolemia (HoFH), and Tangier Disease.
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Apolipoprotein C2 Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial HypercholesterolemiaMs. Khalil-Abou isAdvanced. Learn about Familial Hypercholesterolemia.
- Experienced
- Apolipoprotein C2 DeficiencyMs. Khalil-Abou isExperienced. Learn about Apolipoprotein C2 Deficiency.
- Childhood PancreatitisMs. Khalil-Abou isExperienced. Learn about Childhood Pancreatitis.
- Defective Apolipoprotein B-100Ms. Khalil-Abou isExperienced. Learn about Defective Apolipoprotein B-100.
- Familial HypobetalipoproteinemiaMs. Khalil-Abou isExperienced. Learn about Familial Hypobetalipoproteinemia.
- Familial Lipoprotein Lipase DeficiencyMs. Khalil-Abou isExperienced. Learn about Familial Lipoprotein Lipase Deficiency.
- Heterozygous Familial Hypercholesterolemia (HeFH)Ms. Khalil-Abou isExperienced. Learn about Heterozygous Familial Hypercholesterolemia (HeFH).